NASDAQ: GRAL - GRAIL, LLC

Rentabilité sur six mois: +111.82%
Rendement en dividendes: 0.00%
Secteur: Healthcare

Calendrier des promotions GRAIL, LLC

Calendrier avancé Graphique simple
Financial Markets by TradingView

À propos de l'entreprise GRAIL, LLC

GRAIL, Inc., a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. It is also developing minimal residual disease and other post-diagnostic tests. The company was incorporated in 2015 and is based in Menlo Park, California. GRAIL, Inc. operates as a former subsidiary of Illumina, Inc.

Ajouter à la liste de comparaison
Ajouter à la liste de surveillance
Ajouter au portefeuille
Ajouter un avis de prix

IPO date 2024-06-25
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://grail.com
Цена ао 26.92
Changement de prix par jour: 0% (29.74)
Changement de prix par semaine: -7.32% (32.09)
Changement de prix par mois: -43.44% (52.58)
Changement de prix sur 3 mois: +30.78% (22.74)
Changement de prix sur six mois: +111.82% (14.04)
Evolution des prix depuis le début de l'année: +64.4% (18.09)
Tous les paramètres

Sous-estimation

Nom Signification Grade
P/S 0 0
P/BV 0 0
P/E 0 0
EV/EBITDA 0.0202 10
Total: 3.75

Efficacité

Nom Signification Grade
ROA, % -32.16 0
ROE, % -40.2 0
Total: 0

Dividendes

Nom Signification Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Devoir

Nom Signification Grade
Debt/EBITDA -0.1323 10
Total: 10

Impulsion de croissance

Nom Signification Grade
Rentabilité Revenue, % 537.18 10
Rentabilité Ebitda, % 155.37 10
Rentabilité EPS, % 499.75 10
Total: 10
Plus de détails

ETFPartager, %Rentabilité pour l'année, %Dividendes, %
Principal Healthcare Innovators ETF 0.04203 618.5 0.8416
Future Tech ETF 0.04203 426.34 0.8416
iShares Russell Mid-Cap Value ETF 0.00401 18.01 2.03934
iShares Russell Midcap ETF 0.00308 20.77 1.71565
iShares Russell 1000 Value ETF 0.00147 17.45 2.15361
iShares U.S. Tech Independence Focused ETF 0.00083 34.94 0.84412
iShares Russell 3000 ETF 0.00067 24.83 1.43482
0.01165.831.41



Superviseur Titre d'emploi Paiement Année de naissance
Mr. Robert P. Ragusa CEO & Director 1960 (65 années)
Dr. Joshua J. Ofman M.D., M.S.H.S President 1965 (60 années)
Mr. Aaron Freidin Chief Financial Officer
Mr. Paul Ciccolella Senior VP of Global Development & Operations
Ms. Amoolya Singh Ph.D. Senior VP of Research & Chief Scientific Officer
Mr. Abram Barth J.D., M.P.H. General Counsel
Ms. Julie Currie Chief People Officer
Mr. Rodger Currie VP and Head of Government Affairs & Alliance Development
Sir Harpal S. Kumar M.A., M.B.A., MA, MBA, MEng President Biopharma Business & Europe
Dr. Satnam Alag Ph.D. Senior VP of Software Engineering & Chief Security Officer

Adresse: United States, Menlo Park, 1525 O’Brien Drive - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://grail.com